OnConquer Medical Finalizes Pre-Seed Round with Support from Israel Innovation Authority
OnConquer Medical has finalized its pre-seed funding round with support from the Israel Innovation Authority (IIA). The funding will support the company’s early development efforts and advance its strategy to address metastatic risk in cancer patients.
